Skip to content

2 Under-The-Radar Biotech Stocks To Buy In 2023

Over the past couple of years, biotech players working on coronavirus vaccines and treatments have taken center stage. And some still make great investment choices. But there also are many other treatment areas and companies in the biotech space that are worth investors’ attention.

Right now, I’m thinking about two companies specializing in oncology. They’ve got products on the market and exciting pipelines. In fact, these players have what it takes to deliver growth today and over time. Let’s take a look at these innovative under-the-radar biotech stocks to add to your portfolio this year.

This post originally appeared at The Motley Fool.